Forest Laboratories announced today that the company will discontinue sale of memantine (Namenda) 5-mg and 10-mg tablets effective August 15, 2014, in favor of focusing on sales of its once-daily ...
Forest Laboratories ($FRX) wants more people to use its once-daily version of Namenda. It is, after all, the formula launched just last year, the one that ...
Deprescribing ChEIs/memantine can reduce the risk for ADRs and drug-drug and drug-disease interactions. It can also reduce the pill burden for patients and improve adherence to other medications, as ...
NEW YORK, Feb 14, 2014 (BUSINESS WIRE) -- Forest Laboratories, Inc. FRX +1.49%, a leading, fully integrated, specialty pharmaceutical company largely focused on the United States market, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results